Neonatal effects of maternal antiphospholipid syndrome

Current Rheumatology Reports

Volumn 11, Issue 1, 2009, Pages 70-76

  Tincani, Angela ^a   Rebaioli, Chiara Biasini ^a   Andreoli, Laura ^a   Lojacono, Andrea ^a   Motta, Mario ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY;

ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; BRAIN DEVELOPMENT; CHROMOSOME ABERRATION; COMPLEMENT ACTIVATION; DEVELOPMENTAL DISORDER; FETUS DEATH; FETUS DEVELOPMENT; HELLP SYNDROME; HUMAN; MATERNAL HYPERTENSION; NEWBORN DISEASE; NONHUMAN; PATHOGENESIS; PLACENTA DISORDER; PLACENTA INSUFFICIENCY; PLACENTAL TRANSFER; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURITY; REVIEW; SPONTANEOUS ABORTION; THROMBOSIS; ADULT; ANIMAL; FEMALE; FETOMATERNAL TRANSFUSION; FOLLOW UP; IMMUNOLOGY; LEARNING DISORDER; MOUSE; NEWBORN; PREGNANCY; PSYCHOLOGICAL ASPECT;

ADULT; ANIMALS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LEARNING DISORDERS; MATERNAL-FETAL EXCHANGE; MICE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; YOUNG ADULT;

EID: 63449094208     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0010-8     Document Type: Review

References (50)

1. Soulier JP, Boffa MC: Avortments à repetition, thromboses et anticoagulant circulant antithromboplastin. Nouv Presse Med 1980, 9:859-864.
2. Harris EN, Gharavi AE, Boey ML, et al.: Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983, 2:1211-1214.
3. Tincani A, Balestrieri G, Danieli E, et al.: Pregnancy complications of the antiphospholipid syndrome. Autoimmunity 2003, 36:27-32.
4. Lubbe WF, Butler WS, Palmer SJ, Liggins GC.: Fetal survival after prednisone suppression of maternal lupusanticoagulant. Lancet 1983, 1:1361-1363.
5. Wilson WA, Gharavi AE, Koike T, et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
6. Meroni PL, Gerosa M, Raschi E, et al.: Updating on pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Clinic Rev Allerg Immunol 2008, 34:332-337.
7. Tincani A, Bazzani C, Zingarelli S, Lojacono A: Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: Clinical characteristics, diagnosis, pathogenesis and treatment. Semin Thromb Hemost 2008, 34: 267-273.
8. Holers VM, Girardi G, Mo L, et al.: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002, 195:211-220.
9. Girardi G, Berman J, Redecha P, et al.: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003, 112:1644-1654.
10. Shamonki JM, Salmon JE, Hyjek E, Baergen RN: Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 2007, 196:167.e1-e5.
11. Cavazzana I, Nebuloni M, Cetin I, et al.: Complement activation in antiphospholipid syndrome: A clue for an inflammatory process? J Autoimmun 2007, 28:160-164.
12. Martinez de la Torre Y, Buracchi C, Borroni EM, et al.: Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A 2007, 104:2319-2324.
13. Borghi MO, Raschi E, Scurati S, et al.: Effects of a Toll-like receptor antagonist and anti-annexin A2 antibodies on binding and activation of decidual cells by anti-beta2glycoprotein I antibodies. Clin Exp Rheumatol 2007, 2:35.
14. Meroni PL, Di Simone N, Testoni C, et al.: Antiphospholipid antibodies as cause of pregnancy loss. Lupus 2004, 13:649-652.
15. Miyakis S, Lockshin MD, Atsumi T, et al.: International Consensus Statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 2006, 4:295-306.
16. Oshiro BT, Silver RM, Scott JR, et al.: Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996, 87: 489-493.
17. Rasmussen A, Ravn P: High frequency of congenital thrombophilia in women with pathological pregnancies? Acta Obstet Gynecol Scand 2004, 83:808-817.
18. Asherson RA: New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Autoimmun Rev 2006, 6:76-80.
19. Branch DW, Dudley DJ, Scott JR, Silver RM: Antiphospholipid antibodies and fetal loss. N Engl J Med 1992, 326:952.
20. Scott RA: Anti-cardiolipin antibodies and pre-eclampsia. Br J Obstet Gynecol 1987, 94:604-605.
21. Clark EA, Silver RM, Branch DW: Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 2007, 9:219-225.
22. Faden D, Tincani A, Tanzi P, et al.: Anti-beta 2 glycoprotein I antibodies in a general obstetric population: Preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997, 73:37-42.
23. Asherson RA, Galarza-Maldonado C, Sanin-Blair J: The HELLP syndrome, antiphospholipid antibodies, and syndromes. Clin Rheumatol 2008, 27:1-4.
24. Le Thi Thuong D, Tieulié N, Costedoat N, et al.: The HELLP syndrome in the antiphospholipid syndrome: Retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005, 64:273-278.
25. Tsirigotis P, MantzioA G, Pappa V, et al.: Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome. Rheumatol Int 2007, 28:171-174.
26. Lima F, Khamashta MA, Buchanan NM, et al.: A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996, 14:131-136.
27. Zurgil N, Bakimer R, Tincani A, et al.: Detection of antiphospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus 1993, 2:233-237.
28. Cohen SB, Goldenberg M, Rabinovici J, et al.: Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome. Hum Reprod 2000, 15:1170-1172.
29. Motta M, Chirico G, Rebaioli CB, et al.: Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: A follow-up study. Am J Perinatol 2006, 23:247-251.
30. Pollard JK, Scott JR, Branch DW: Outcome of children born to women treated during pregnancy for the antiphospholipid syndrome. Obstet Gynecol 1992, 80:365-368.
31. Botet F, Romera G, Montagut P, et al.: Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med 1997, 25:192-196.
32. Ruffatti A, Dalla Barba B, Del Ross T, et al.: Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy. Clin Exp Rheumatol 1998, 16:605-610.
33. Brewster JA, Shaw NJ, Farquharson RG: Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med 1999, 27:183-187.
34. Tincani A, Lojacono A, Taglietti M, et al.: Pregnancy and neonatal outcome in primary antiphospholipid syndrome. Lupus 2002, 11:649.
35. Boffa MC, Lachassinne E: Infant perinatal thrombosis and antiphospholipid antibodies: A review. Lupus 2007, 16:634-641.
36. Avcin T, Cimaz R, Meroni PL: Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002, 11:4-10.
37. Boffa MC, Aurousseau MH, Lachassinne E, et al.: European register of babies born to mothers with antiphospholipid syndrome. Lupus 2004, 13:713-717.
38. Blank M, Shoenfeld Y: Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 2004, 112:190-199.
39. Martinuc Porobic J, Avcin T, Bozic B, et al.: Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol 2005, 142:377-380.
40. Chapman J, Shoenfeld Y: Neurological and neuroendocrine cytokine inter-relationship in the antiphospholipid syndrome. Ann N Y Acad Sci 2002, 966:415-424.
41. Shoenfeld Y, Nahum A, Korczyn AD, et al.: Neuronalbinding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 2003, 12:436-442.
42. Kent M, Alvarez F, Vogt E, et al.: Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol 1997, 24:1725-1733.
43. Muscal E, Brey RL: Neurological manifestations of the antiphospholipid syndrome: Integrating molecular and clinical lessons. Curr Rheumathol Rep 2008, 10:67-73.
44. Prendiville JS, Cabral DA, Poskitt KJ, et al.: Central nervous system involvement in neonatal lupus erythematosus. Pediatr Dermatol 2003, 20:60-67.
45. Zuppa AA, Gallini F, De Luca D, et al.: Cerebral ultrasound findings in neonatal lupus syndrome. Biol Neonate 2004, 86:230-234.
46. Inoue K, Fukushige J, Ohno T, et al.: Central nervous system vasculopathy associated with neonatal lupus. Pediatr Neurol 2002, 26:68-70.
47. McAllister DL, Kaplan BJ, Edworthy SM, et al.: The influence of systemic lupus erythematosus on fetal development: Cognitive, behavioral, and health trends. Int Neuropsychol Soc 1997, 3:370-376.
48. Ross G, Sammaritano L, Nass R, Lockshin M: Effects of mothers' autoimmune diseases during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003, 157:397-402.
49. Neri F, Chimini L, Bonomi F, et al.: Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 2004, 13:805-811.
50. Nacinovich R, Galli J, Bomba M, et al.: Neuropsycological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum 2008, 59:345-351.